title: Viridans group streptococci in febrile neutropenic cancer patients: what should we fear?
authors.affiliation: Division of Infectious Diseases, University of Nebraska Medical Center, Omaha.
authors.forename: Alison G
authors.initials: AG
authors.lastname: Freifeld
authors.affiliation: Division of Infectious Diseases, and the William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, Minnesota.
authors.forename: Raymund R
authors.initials: RR
authors.lastname: Razonable
mesh_terms: D016470:Bacteremia / Q000382:microbiology*; D003661:Decision Support Techniques; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000150:complications*; D009503:Neutropenia / Q000150:complications*; D013290:Streptococcal Infections / Q000382:microbiology*; D034363:Viridans Streptococci / Q000187:drug effects*; D018440:beta-Lactam Resistance
keywords: bloodstream infection; febrile neutropenia; viridans streptococci